Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Medtech 360 | Market Analysis | Japan | 2018

The mature Japanese CRM device market will remain flat through 2026, characterized by low generator unit volume growth, rising ICM procedure volumes, and price erosion. The uptake of premium-priced devices such as CRT devices, leadless pacemakers, and S-ICDs will help mitigate the downward pressure of reimbursement cuts over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will experience moderate growth through 2034. This update reflects the impact of recent developments, including the launch of new-generation devices and…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Gynecological Devices – Market Insights – Japan
The Japanese gynecological device market will experience slow but steady growth over the forecast period, driven primarily by increasing awareness among women regarding gynecological health and…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…